Recap and Outlook of Worldwide Edge Computing Industry and Technology, 2020-2021

Globe Newswire

Global Cloud Storage Market to Reach $204.4 Billion by 2027

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 9. - Influencer Pool: 2352. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Decision Support Systems Industry" - https://www.reportlinker.com/p06040513/?utm_source=GNW In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack. - Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations. Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations. Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives. Abstract: - Global Clinical Decision Support Systems Market to Reach $2.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Clinical Decision Support Systems estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Hardware, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$669.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 13.1% CAGR for the next 7-year period. - The U.S. Market is Estimated at $322 Million, While China is Forecast to Grow at 9.8% CAGR - The Clinical Decision Support Systems market in the U.S. is estimated at US$322 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$375.7 Million by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR. - Services Segment to Record 9.6% CAGR - In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$380 Million in the year 2020 will reach a projected size of US$725.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$253.1 Million by the year 2027. - Select Competitors (Total 43 Featured) - Allscripts Healthcare Solutions, Inc.Cerner CorporationElsevier BVEpic Systems CorporationHearst HealthIBM CorporationMcKesson CorporationMEDITECHPhilips HealthcareWolters Kluwer Health Read the full report: https://www.reportlinker.com/p06040513/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Cloud-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for On-premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for On-premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for On-premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Standalone CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Standalone CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Standalone CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Integrated CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Integrated CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Integrated CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Conventional CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Conventional CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Conventional CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Advanced CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Advanced CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Advanced CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Therapeutic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Therapeutic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Therapeutic CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 34: World Current & Future Analysis for Diagnostic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 35: World Historic Review for Diagnostic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: World 15-Year Perspective for Diagnostic CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 37: USA Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 46: USA Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: USA Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: USA 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 49: USA Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: USA Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: USA 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 CANADA Table 52: Canada Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 55: Canada Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Canada Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Canada 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 58: Canada Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Canada Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Canada 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 61: Canada Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Canada Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Canada 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 64: Canada Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Canada Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Canada 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 JAPAN Table 67: Japan Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Japan Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Japan 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 70: Japan Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: Japan Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Japan 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 73: Japan Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Japan Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Japan 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 76: Japan Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Japan Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Japan 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 79: Japan Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Japan Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Japan 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 CHINA Table 82: China Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: China Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: China 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 85: China Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: China Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: China 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 88: China Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: China Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: China 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 91: China Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: China Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: China 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 94: China Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: China Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: China 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 EUROPE Table 97: Europe Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 98: Europe Historic Review for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Europe 15-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 100: Europe Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Europe Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Europe 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 103: Europe Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Europe Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Europe 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 106: Europe Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Europe Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Europe 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 109: Europe Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Europe Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Europe 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 112: Europe Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Europe Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Europe 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 FRANCE Table 115: France Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: France Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: France 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 118: France Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: France Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: France 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 121: France Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: France Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: France 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 124: France Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: France Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: France 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Table 127: France Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: France Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: France 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027 GERMANY Table 130: Germany Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Germany Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Germany 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027 Table 133: Germany Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 134: Germany Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: Germany 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027 Table 136: Germany Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: Germany Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: Germany 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027 Table 139: Germany Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 140: Germany Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 141: Germany 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027 Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06040513/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Comments are closed.